ChinaBio® Partnering Forum 2017: Rapid change: Good times for pharma?

June 5, 2017
Everything in China seems to be on the fast track. This is especially true in the pharma industry, where new announcements affecting regulations, pricing, and reimbursement are occurring on nearly a daily basis. How are Western pharma companies reacting to these changes? Is it going to be easier and faster to gain approval for Western drugs in China? Will this stimulate or impede local R&D and partnering activity?
Previous Video
ChinaBio® Partnering Forum 2017: Funding drug development in China through VCs and partnerships
ChinaBio® Partnering Forum 2017: Funding drug development in China through VCs and partnerships

Western and China companies are leveraging the significant funding and support available in China to develo...

Next Video
BIO-Europe® 2017: Join us in Berlin
BIO-Europe® 2017: Join us in Berlin

Don’t miss Europe’s largest annual life science conference in Berlin, November 6–8, 2017. We offer powerful...